 |
|---|
Expansion of U.S. Distribution Network Announced
|
VICTORIA, B.C., July 30, 2003 - CardioComm Solutions Inc. (TSX-V:CCG) (the "Company", "CardioComm"), is pleased to provide the following update:
Distribution Agreements CardioComm has engaged three new U.S. based manufacturer's representatives to market its full complement of software products. The new manufacturer's representatives will work under the auspices of CardioComm's direct sales force. The addition of the reps will expand the Company's distribution channels, which already include key distribution agreements with leading industry distributors such as Instromedix (a division of Card Guard Technologies), Philips Medical Systems (a division of Royal Philips Electronics), and Braemar Inc. The manufacturer's representatives will cover territories in the Northeast, Southeast, and Midwestern United States. CardioComm intends to have seven such agreements, covering other regions, signed by the end of the third quarter.
Investment by Biomedical Systems Inc. Pursuant to the Company's news release dated August 27, 2002, CardioComm is pleased to announce that it is expanding its business relationship with Biomedical Systems Inc. of St. Louis, Missouri. Biomedical Systems provides services for pharmaceutical, cardiology and perinatal studies and patient monitoring. After a year of working very well together, Biomedical Systems opted to invest US$250,000 in CardioComm through its recently announced convertible promissory note offering. In addition, the two companies have decided to expand their relationship with an anticipated launch designed to enhance Biomedical Systems' clinical services division which provides event monitoring and trans-telephonic pacemaker follow up. CardioComm's GlobalCardio TM product has and will continue to be customized and enhanced as needed to ensure Biomedical Systems' leadership using the efficiencies of web-based solutions.
About CardioComm Solutions Inc: CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS™) and GlobalCardio™ . CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has both ISO 9001 and EN 46001 certifications.
|
On behalf of the Board of Directors of CardioComm Solutions Inc.:
“Stephen Martin”
Stephen R. Martin, President & CEO
For investor information, please contact: Stephen Martin |
